SCHEMBL6826832

SCHEMBL6826832

CCCCOC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.53
KMT2A Q03164 1/20 0.53
CNR1 P21554 1/20 0.53
CNR2 P34972 1/20 0.53
LNPEP Q9UIQ6 3/20 0.52
TSHR P16473 2/20 0.52
MDM4 O15151 1/20 0.52
MDM2 Q00987 1/20 0.52
ERAP2 Q6P179 4/20 0.49
ERAP1 Q9NZ08 2/20 0.49
IL1RN P18510 2/20 0.49
ESR1 P03372 2/20 0.49
ESR2 Q92731 1/20 0.49
CDK2 P24941 1/20 0.48
NLRP3 Q96P20 1/20 0.48
POLB P06746 1/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008631 1.00 NPSR1 (0.53) NPSR1KMT2ACNR1CNR2LNPEP
SCHEMBL1721283 1.00 NPSR1 (0.53) NPSR1KMT2ACNR1CNR2LNPEP
SCHEMBL31390194 0.91 CNR1 (0.48) NPSR1KMT2ACNR1CNR2LNPEP
SCHEMBL8234170 0.90 POLB (0.48) TSHRPOLBCYP2C19ALDH1A1
SCHEMBL2252892 0.90 FOLH1 (0.56) TSHRESR1LMNACYP1A2CYP2D6
SCHEMBL2252894 0.90 FOLH1 (0.56) TSHRESR1LMNACYP1A2CYP2D6
SCHEMBL8019599 0.88 POLB (0.47) TSHRPOLB
SCHEMBL8234657 0.88 POLB (0.47) TSHRPOLB
SCHEMBL7495527 0.88 TSHR (0.49) LNPEPTSHRERAP2ERAP1POLB
SCHEMBL842451 0.88 CNR1 (0.52) NPSR1KMT2ACNR1CNR2LNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6740637-B1 PHOTODYNAMIC THERAPY (PDT) PHOTOSENSITIZERS; TUMOR DIAGNOSIS; CONJUGATION WITH CELL-SPECIFIC LIGANDS, TARGET THE TUMOR SITE; MELANOCYTE STIMULATING HORMONES CONJUGATES ARE SUITABLE FOR PDT OF MELANOMA TUMORS YEDA RESEARCH AND DEVELOPMENT CO. (IL) 2004-05-25 US disclosed